MedTrace Logo

The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer

NCT04699760 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-01-07

No results posted yet for this study

Summary

The aim of this study is to determine the effects of n-3 PUFAs on weight, physical funktion and quality of life in patients with colorectal cancer.

Conditions

  • Cancer Cachexia
  • Side Effects
  • Quality of Life

Interventions

DIETARY_SUPPLEMENT

Fish Oil

8 weeks, 2.2 G EPA/day

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Jens R Andersen · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699760 on ClinicalTrials.gov